317 related articles for article (PubMed ID: 23432579)
1. RNAi in clinical studies.
Kubowicz P; Żelaszczyk D; Pękala E
Curr Med Chem; 2013; 20(14):1801-16. PubMed ID: 23432579
[TBL] [Abstract][Full Text] [Related]
2. RNA interference and cancer therapy.
Wang Z; Rao DD; Senzer N; Nemunaitis J
Pharm Res; 2011 Dec; 28(12):2983-95. PubMed ID: 22009588
[TBL] [Abstract][Full Text] [Related]
3. Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression.
He S; Zhang D; Cheng F; Gong F; Guo Y
Mol Biol Rep; 2009 Nov; 36(8):2153-63. PubMed ID: 19117119
[TBL] [Abstract][Full Text] [Related]
4. Noncoding RNA for Cancer Gene Therapy.
Zhong X; Zhang D; Xiong M; Zhang L
Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
[TBL] [Abstract][Full Text] [Related]
5. In vivo delivery aspects of miRNA, shRNA and siRNA.
Khatri N; Rathi M; Baradia D; Trehan S; Misra A
Crit Rev Ther Drug Carrier Syst; 2012; 29(6):487-527. PubMed ID: 23176057
[TBL] [Abstract][Full Text] [Related]
6. The dicey role of Dicer: implications for RNAi therapy.
Merritt WM; Bar-Eli M; Sood AK
Cancer Res; 2010 Apr; 70(7):2571-4. PubMed ID: 20179193
[TBL] [Abstract][Full Text] [Related]
7. In vivo application of RNA interference: from functional genomics to therapeutics.
Lu PY; Xie F; Woodle MC
Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
[TBL] [Abstract][Full Text] [Related]
8. [In vivo siRNA delivery to tumor cells and its application to cancer gene therapy].
Takahashi Y; Nishikawa M; Takakura Y
Yakugaku Zasshi; 2007 Oct; 127(10):1525-31. PubMed ID: 17917414
[TBL] [Abstract][Full Text] [Related]
9. An update on RNA interference-mediated gene silencing in cancer therapy.
Ren YJ; Zhang Y
Expert Opin Biol Ther; 2014 Nov; 14(11):1581-92. PubMed ID: 25010067
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
[TBL] [Abstract][Full Text] [Related]
11. [Combinatorial RNAi and its application in cancer gene therapy].
Fei LN; Wang QZ; Xu RA
Yao Xue Xue Bao; 2012 May; 47(5):573-9. PubMed ID: 22811998
[TBL] [Abstract][Full Text] [Related]
12. Advances, nuances, and potential pitfalls when exploiting the therapeutic potential of RNA interference.
Battistella M; Marsden PA
Clin Pharmacol Ther; 2015 Jan; 97(1):79-87. PubMed ID: 25670385
[TBL] [Abstract][Full Text] [Related]
13. Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.
Singh S; Narang AS; Mahato RI
Pharm Res; 2011 Dec; 28(12):2996-3015. PubMed ID: 22033880
[TBL] [Abstract][Full Text] [Related]
14. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
[TBL] [Abstract][Full Text] [Related]
16. RNAi and miRNA in viral infections and cancers.
Mollaie HR; Monavari SH; Arabzadeh SA; Shamsi-Shahrabadi M; Fazlalipour M; Afshar RM
Asian Pac J Cancer Prev; 2013; 14(12):7045-56. PubMed ID: 24460249
[TBL] [Abstract][Full Text] [Related]
17. Illuminating the gateway of gene silencing: perspective of RNA interference technology in clinical therapeutics.
Sindhu A; Arora P; Chaudhury A
Mol Biotechnol; 2012 Jul; 51(3):289-302. PubMed ID: 21947958
[TBL] [Abstract][Full Text] [Related]
18. Potential use of RNA interference in cancer therapy.
Phalon C; Rao DD; Nemunaitis J
Expert Rev Mol Med; 2010 Aug; 12():e26. PubMed ID: 20716384
[TBL] [Abstract][Full Text] [Related]
19. siRNA vs. shRNA: similarities and differences.
Rao DD; Vorhies JS; Senzer N; Nemunaitis J
Adv Drug Deliv Rev; 2009 Jul; 61(9):746-59. PubMed ID: 19389436
[TBL] [Abstract][Full Text] [Related]
20. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins.
Boden D; Pusch O; Silbermann R; Lee F; Tucker L; Ramratnam B
Nucleic Acids Res; 2004; 32(3):1154-8. PubMed ID: 14966264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
